The EEG system developer raised the series B funding from investors including UCB and LivaNova and will use it commercialise its lead device.

Novo has co-led the series B round together with Omega Funds, adding to a $51.5m series A co-led by GlaxoSmithKline and Pfizer in 2016.

The software-testing automation technology developer took its total funding to $30m with a GV-led series B round.

The Huishoubao-backed electronics repair service raised $11.7m at a $145m valuation in a round led by SanXiaXinTai Fund.

The marketing data software provider increased its overall funding to $50m in a series B round featuring returning investor Telstra Ventures.

The second tranche of an Astremedia and Channel 4-backed series B round increased it to $36m, as hiring platform Job Today looks to UK growth.

TAL Education's Win-Win Fund co-led a $17.5m round for All Dream Network Technology, operator of a coding education platform.

The fibre optic network operator raised the cash in a round co-led by Mitsui, and is looking to add a $40m debt facility.

Zalando and Children’s Investment Fund Foundation have added $2.5m to Working Capital's supply chain-focused fund, which now stands at $25.2m.

Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.